Where is Prime speaking & sponsoring?
1) Doubling of Members with Extremely High Annual Drug Costs (2016-2019); Kevin Bowen, MD, MBA – principal researcher, health outcomes; Patrick P. Gleason, PharmD, BCPS, FCCP, FAMCP – assistant vice president, health outcomes
2) Is Medicare Star Category Medication Adherence Associated with Lower Total Cost of Care and Medical Events?; Yang Qiu, MS – principal data scientist, health outcomes; Pinar Karaca Mandic, PhD, professor, University of Minnesota – Carlson School of Management; Patrick P. Gleason, PharmD, BCPS, FCCP, FAMCP – assistant vice president, health outcomes
3) Stage IV Melanoma Comparison of Drug Regimens Persistence; Devin Gerboth, PharmD candidate, University of Washington, Seattle – AMCP Foundation/Pfizer, Inc./Prime Therapeutics Oncology summer intern; Jeremy Whalen, PharmD, BCOP – specialty clinical program director, oncology; Patrick P. Gleason, PharmD, BCPS, FCCP, FAMCP – assistant vice president, health outcomes; Kevin Bowen, MD, MBA - principal researcher, health outcomes
4) Sacubitril-Valsartan Real World Assessment (Platinum Award Winner/Presenter); James Burke, researcher, health outcomes; Brett Sahli, senior director, health outcomes and value; Patrick P. Gleason, PharmD, BCPS, FCCP, FAMCP – assistant vice president, health outcomes
Customer Contact Strategies’ Work From Home Senior Leadership Forum
Virtual Session: Lessons learned: the rapid shift to 100% at home due to pandemic
Presenters: Dan White, Director of Operations Clinical Review
Noon – 1 p.m.
Webinar: A critical collaboration between a pharmacy benefit manager and health plan during COVID-19 pandemic: Blue Cross and Blue Shield of Minnesota & Prime Therapeutics share challenges and successes
Presenters: David Lassen, PharmD, Chief Clinical Officer; Randall (Randy) Hanna, R.Ph., vice president, pharmacy, Blue Cross and Blue Shield of Minnesota